ChemoCentryx to Present at the H.C. Wainwright Global Investment Conference
May 16 2022 - 8:30AM
ChemoCentryx, Inc., (Nasdaq: CCXI), today announced that Thomas J.
Schall, Ph.D., President and Chief Executive Officer, will present
at the H.C. Wainwright Global Investment Conference on Tuesday, May
24, 2022 at 12:30 p.m. ET. The conference will be held at the
Fontainebleau Miami Beach Hotel in Miami, FL.
A live audio webcast of the presentations can be
accessed through the Investors section of the Company's website at
www.ChemoCentryx.com. A replay of the webcast will be available on
the Company's website for two weeks following the live
presentation.
About ChemoCentryx
ChemoCentryx is a biopharmaceutical company
commercializing and developing new medications for inflammatory and
autoimmune diseases and cancer. ChemoCentryx targets the chemokine
and chemoattractant systems to discover, develop and commercialize
orally administered therapies. In the United States, ChemoCentryx
markets TAVNEOS® (avacopan), the first approved orally administered
inhibitor of the complement 5a receptor as an adjunctive treatment
for adult patients with severe active ANCA-associated vasculitis.
TAVNEOS is also in late-stage clinical development for the
treatment of severe Hidradenitis Suppurativa (HS) and C3
glomerulopathy (C3G). Additionally, ChemoCentryx has early-stage
drug candidates that target chemoattractant receptors in other
inflammatory and autoimmune diseases and in cancer. For more
information about the Company visit www.chemocentryx.com.
TAVNEOS® is a registered trademark of ChemoCentryx,
Inc. For more information, please see the Full Prescribing
Information and Medication Guide, available at TAVNEOS.com.
Contacts:
Investors:Bill Slattery, Jr.Vice
President, Investor Relations& Corporate
Communications650.210.2970bslattery@chemocentryx.com
Media:Stephanie
Tomei408.234.1279media@chemocentryx.com
ChemoCentryx (NASDAQ:CCXI)
Historical Stock Chart
From Aug 2024 to Sep 2024
ChemoCentryx (NASDAQ:CCXI)
Historical Stock Chart
From Sep 2023 to Sep 2024